Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement

5 Feb 2014 10:25

THE INCOME & GROWTH VCT PLC - Interim Management Statement

THE INCOME & GROWTH VCT PLC - Interim Management Statement

PR Newswire

London, February 5

The Income & Growth VCT plc ("the Company") INTERIM MANAGEMENT STATEMENT For the quarter ended 31 December 2013 In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UKListing Authority, The Income & Growth VCT plc presents an Interim ManagementStatement for the quarter ended 31 December 2013. The statement also includesrelevant financial information between the end of the period and the date ofthis statement. NET ASSET VALUE AND TOTAL RETURN PER SHARE At 31 December 2013 At 30 September 2013 Net assets attributable to £60,778,363 £60,468,872shareholders Shares in issue 52,964,001 53,088,219 Net asset value (NAV) per share 114.75p 113.90p Net cumulative dividends paid per 40.50p 40.50pshare Cumulative total return per share 155.25p 154.40p (NAV basis) since launch INVESTMENTS In November 2013, the Company completed a new investment of £2,844,000(including £1 million from the acquisition vehicle Culbone Trading Limited) tosupport the MBO of Virgin Wines Online Limited one of the UK's leading onlineretailers of wine. Following the period-end in January 2014, the Company completed a further newinvestment of £1,610,000 to provide development capital to Bourn BioscienceLimited, one of the UK's leading IVF/assisted fertility businesses with adominant presence in East Anglia. DIVESTMENTS The Company realised its investment in Alaric Systems Limited ("Alaric") aprovider of payment processing and fraud prevention software, in December 2013through a sale to a subsidiary of NCR Corporation for cash proceeds of £2.55million. This realisation has contributed to total receipts of £2.65 million bythe Company over the life of the investment, representing a return of over 4.4times original cost of £0.60 million. In November and December 2013, the VCT received final repayments of loan stockfrom Faversham House Holdings Limited which generated net proceeds of £165,000(including a premium of £21,000). The Company has now fully realised thisinvestment, from which it has received 93% of original cost of £488,000 on atotal return basis. During the quarter, the Company received loan stock repayments totalling £479,000 (including premia) from Tessella Holdings Limited, DiGiCo GlobalLimited, Focus Pharma Holdings Limited and Blaze Signs Holdings Limited. Afurther £493,000 in deferred consideration was also received, relating to thesale of App-DNA in November 2012. Following the period-end, a further payment of £100,000 has been received fromWestway Services Holdings Limited (including a premium of £31,000). DIVIDENDS A final dividend of 4 pence per share has been proposed for consideration byshareholders at the Annual General Meeting of the Company to be held on, 12February 2014. The dividend comprises 1.25 pence from income and 2.75 pencefrom capital and will, if approved, be paid to shareholders on the register on21 February 2014, on 12 March 2014. This would bring dividends paid in respectof the year ended 30th September 2013 to 10 pence per share. SHARE BUY-BACKS The Company bought back 124,218 of its own shares on 18 December 2013 at 99.00pence per share. MOBEUS VCTs' JOINT OFFER FOR SUBSCRIPTION Together with Mobeus Income & Growth VCT plc, Mobeus Income & Growth 2 VCT plcand Mobeus Income & Growth 4 VCT plc, the Company is participating in theMobeus VCTs' Linked Offer. This was launched on 28 November 2013 to raise up to£24 million across the four VCTs of which up to £6 million will be allocated tothe VCT ("the Offer"). The Offer will remain open until 12.00 noon on 30 April 2014 (4 April 2014 inrespect of the current tax year) although the Directors of the four VCTsreserve the right to extend the closing date at their discretion. Applications totalling £12 million have been received under the Offer to date,£3 million of which are in respect of this Company. ISSUE OF EQUITY In respect of the applications above received up to 3rd February 2014, theCompany has to date allotted 851,426 shares under the Offer at prices between117.71621 and 120.21543 pence per share on 9 January 2014, raising net funds of£971,000. For further information, please contact: Robert Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 70247600.
Date   Source Headline
20th Dec 20194:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
16th Dec 20199:45 amRNSTransaction in Own Shares
13th Dec 20194:30 pmRNSAnnual Financial Report
6th Dec 20194:45 pmRNSDividend Investment Scheme - Recommencement
6th Dec 20194:45 pmRNSAnnual Results for the year ended 30 Sep 2019
26th Nov 20194:09 pmRNSDirector Declaration
14th Nov 201912:00 pmRNSFundraising Update
12th Nov 20192:30 pmRNSDirectorate Change
25th Oct 20194:00 pmRNSPublication of a Prospectus
18th Oct 20195:20 pmRNSDirectorate Change
3rd Oct 20199:52 amRNSDirector Declaration
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
18th Sep 20194:01 pmRNSDividend Declaration
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
13th Aug 20193:19 pmRNSInterim Management Statement - 3rd Quarter
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:11 amRNSRealisation of investment
7th Jun 20195:35 pmRNSTransaction in Own Shares
5th Jun 20194:44 pmRNSTransaction in Own Shares
4th Jun 201911:05 amRNSHalf-year Report
30th May 20193:38 pmRNSHalf-year Report
26th Mar 20195:25 pmRNSTransaction in Own Shares
15th Feb 20194:30 pmRNSTransaction in Own Shares
6th Feb 20191:54 pmRNSInterim Management Statement - 1st Quarter
6th Feb 20191:42 pmRNSResult of AGM
19th Dec 20184:32 pmRNSTransaction in Own Shares
19th Dec 20183:50 pmRNSAnnual Financial Report
17th Dec 20189:25 amRNSTransaction in Own Shares
12th Dec 20182:25 pmRNSDividend Investment Scheme - Suspension
12th Dec 20182:24 pmRNSFinal Results for year ended 30 September 2018
26th Sep 20184:54 pmRNSTransaction in Own Shares
13th Sep 201811:59 amRNSInterim Management Statement to 30 June 2018
14th Aug 20189:42 amRNSNet Asset Value(s)
20th Jul 20185:41 pmRNSTransaction in Own Shares
2nd Jul 20184:18 pmRNSTotal Voting Rights
21st Jun 20184:24 pmRNSDirector/PDMR Shareholding
21st Jun 20184:20 pmRNSDirector/PDMR Shareholding
21st Jun 20184:19 pmRNSIssue of Equity
11th Jun 201811:13 amRNSTransaction in Own Shares
15th May 201812:59 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.